Professur für Translationale Frauenheilkunde und Geburtshilfe

Event Report 7th Scientific Symposium of AGO-TraFo (2016) Niederacher D, Fasching P, Fehm TN Journal article Does differential HLA-E and -F expression cause an aberrant immune tolerance in preeclampsia and HELLP? (2016) Würfel F, Hübner H, Strick R, Fasching P, Beckmann M, Wuerfel W, Rübner M Conference contribution The DETECT Study Concept - Metastatic breast cancer and circulating tumor cells (2016) Schramm A, Friedl T, Rack B, Trapp E, Fasching P, Taran FA, Hartkopf A, et al. Conference contribution Targeted Intraoperative Radiation Therapy Tumor Bed Boost During Breast-Conserving Surgery After Neoadjuvant Chemotherapy in TNBC and HER2 Positive Breast Cancer (2016) Kolberg HC, Loevey G, Akpolat-Basci L, Stephanou M, Fasching P, Untch M, Liedtke C, et al. Conference contribution Serum carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: a biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial (2016) Janning M, Mueller , Vettorazzi E, Cubas-Cordova M, Gensch , Ben Batalla , Eulenburg ZC, et al. Conference contribution Tumor-infiltrating lymphocytes and response prediction to neoadjuvant chemotherapy in HER2-positive breast cancer (2016) Heppner BI, Untch M, Denkert C, Pfitzner BM, Lederer B, Schmidt W, Eidtmann H, et al. Conference contribution Randomized, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple negative or luminal B/HER2 normal breast cancer (GENEVIEVE) (2016) Paepke S, Huober J, Sherko K, Eidtmann H, Untch M, Costa SD, Blohmer JU, et al. Conference contribution Erratum to: The integrative epigenomic-transcriptomic landscape of ER positive breast cancer (2016) Gao Y, Jones A, Fasching P, Rübner M, Beckmann M, Widschwendter M, Teschendorff AE Journal article Going Digital: A Survey on Digitalization and Large-Scale Data Analytics in Healthcare (2016) Tresp V, Overhage JM, Bundschus M, Rabizadeh S, Fasching P, Yu Shipeng Journal article BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers (2016) Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q, Barrowdale D, et al. Journal article